Close
ACHEMA MIDDLE EAST 2026

Building Regulatory Readiness in Biologics Formulation

The development of biologic therapies demands meticulous navigation through complex regulatory landscapes where scientific innovation must align with evolving compliance frameworks. Regulatory readiness biologics...

Smart Materials for Controlled Release Systems

Smart Materials Driving the Future of Controlled Release The pharmaceutical landscape witnesses transformative advances as smart materials controlled release systems redefine therapeutic delivery paradigms. These...

Formulation Challenges in Biosimilars Development

Overcoming Formulation Barriers in Biosimilars Development The biosimilar landscape represents one of the most dynamic and challenging frontiers in pharmaceutical development, where scientific complexity intersects...

Enhancing Stability in Biologics Formulation

Enhancing Stability and Shelf Life in Biologics Formulation Biologic therapies have revolutionized treatment across diverse disease areas, yet their complex structures and sensitivity to environmental...

FDA Approves Celltrion’s EYDENZELT for Retinal Diseases

Celltrion, Inc. said the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar of EYLEA® (aflibercept), for several retinal conditions. These...

FDA Clears UZEDY Injection for Bipolar I Disorder in Adults

The U.S. Food and Drug Administration (FDA) has approved UZEDY® (risperidone) as a once-monthly, extended-release injectable suspension for adults with bipolar I disorder (BD-I)....

FDA Clears Elecsys pTau181 Alzheimer’s Test by Roche, Lilly

The US Food and Drug Administration (FDA) has approved a new blood test aimed at assessing Alzheimer’s disease and other cognitive impairments, potentially allowing...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...